4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-23-011387
President and CEO sold 27,750 shares at an average $27.23 ($755,517)
- President and CEO disposed of 164,898 shares (other)
- President and CEO acquired 164,898 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCANGOS GEORGE A President and CEO | 2022-12-21 | Other disposition | −49,984 | 827,151 | I | ||
| SCANGOS GEORGE A President and CEO | 2022-12-21 | Other acquisition | +49,984 | 111,644 | I | ||
| SCANGOS GEORGE A President and CEO | 2022-12-21 | Other disposition | −49,984 | 827,151 | I | ||
| SCANGOS GEORGE A President and CEO | 2022-12-21 | Other acquisition | +49,984 | 111,644 | I | ||
| SCANGOS GEORGE A President and CEO | 2023-01-18 | Other disposition | −64,930 | 3,533,629 | I | ||
| SCANGOS GEORGE A President and CEO | 2023-01-18 | Other acquisition | +64,930 | 179,930 | I | ||
| SCANGOS GEORGE A President and CEO | 2023-02-17 | Sale | −9,894 | $25.29 | $250,199 | 214,095 | D |
| SCANGOS GEORGE A President and CEO | 2023-02-21 | Sale | −11,382 | $28.02 | $318,867 | 202,713 | D |
| SCANGOS GEORGE A President and CEO | 2023-02-21 | Sale | −6,474 | $28.80 | $186,451 | 196,239 | D |
| Open-market sales · 27,750 sh · avg $27.23 · $755,517 | |||||||
Loading xslF345X03/doc4.xml…